Remove 05 19 pharma-law-policy-april-2022
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

SQA Regulatory Surveillance Summary for September and October 2022. ANVISA’s Questions & Answers (Q&A) on Medical Cannabis for Clinical Investigations, 14 September 2022. ANVISA published answers to questions received during an online seminar on clinical research of medicinal cannabis held in May 2022. 30 of 2022.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

ANVISA Warns of New Cases of Botulinum Toxin Counterfeiting, 05 April 2023 ANVISA alerts health professionals and the population to the fact that new cases of adulteration/falsification of the drug Botox® 100U (botulinum toxin A), Batch Number C6835C3 have been identified.

FDA 40